Since MuRF1 is considered to be a general marker for skeletal muscle atrophy, our transgenic reporter animals provide an attractive tool to investigate a variety of diseases and/or conditions with atrophy components such as aging, cancer, chronic heart failure, chronic kidney disease, diabetes, or ventilator-induced diaphragmatic dysfunction. Here, TRIM63 is linked to congestive heart failure.